创业板上市公司股权激励计划自查表 | 公司简称：华新环保 | 股票代码：301265 独立财务顾问：无 | | --- | --- | | | 是否存在该 | * [10] M. C. Gonzalez-Garcia, M. C. Gonzalez-Garcia, M. 上市公司合规性要求 最近一个会计年度财务会计报告是否未被注册会计师出具否定 意见或者无法表示意见的审计报告 最近一个会计年度财务报告内部控制是否未被注册会计师出具 否定意见或无法表示意见的审计报告 上市后最近 36 个月内是否未出现过未按法律法规、公司章程、 公开承诺进行利润分配的情形 激励对象合规性要求 是否未包括单独或合计持有上市公司 5%以上股份的股东或实际 控制人及其配偶、父母、子女 是否最近 12 个月内未被中国证监会及其派出机构认定为不适当 人选 是否最近 12 个月内未因重大违法违规行为被中国证监会及其派 出机构行政处罚或者采取市场禁入措施 是否不存在《公司法》规定的不得担任公司董事、高级管理人 员情形 激励计划合规性要求 上市公司全部在有效期内的股权激励计划所涉及的标的股票总 数累计是否未超过公司股本总额的 20% 票是否未超 ...

华新绿源环保股份有限公司董事会薪酬与考核委员会 关于公司 2025 年限制性股票激励计划（草案）的核查意见 （3）最近 12 个月内因重大违法违规行为被中国证监会及其派出机构行政 处罚或者采取市场禁入措施；具有《公司法》规定的不得担任公司董事、高级 管理人员情形的； （4）具有法律法规规定不得参与上市公司股权激励情形的； （1）最近一个会计年度财务会计报告被注册会计师出具否定意见或者无法 表示意见的审计报告； （2）最近一个会计年度财务报告内部控制被注册会计师出具否定意见或无 法表示意见的审计报告； （3）上市最近 36 个月内出现过未按法律法规、公司章程、公开承诺进行 利润分配的情形； （4）法律法规规定不得实行股权激励的； （5）中国证监会认定的其他情形。 （1）最近 12 个月内被证券交易所认定为不适当人选的； （2）最近 12 个月内被中国证监会及其派出机构认定为不适当人选的； 华新绿源环保股份有限公司（以下简称"公司"）董事会薪酬与考核委员会 依据《中华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证券法 》（以下简称《证券法》）《上市公司股权激励管理办法》（以下简称《管理办法》 ）和《 ...

Group 1 - The company held its fourth meeting of the fourth session of the Supervisory Board on May 30, 2025, with all three supervisors present, and the meeting complied with relevant laws and regulations [1][2][5] - The Supervisory Board reviewed and approved the draft of the 2025 Employee Stock Ownership Plan, which aims to enhance the company's sustainable development and does not harm the interests of the company and all shareholders [2][5][6] - The Employee Stock Ownership Plan has been discussed with employees through a representative assembly, ensuring no forced participation [2][5] Group 2 - The Supervisory Board also reviewed the 2025 Stock Incentive Plan draft, which aligns with legal requirements and aims to attract and retain talent while aligning the interests of shareholders and the core team [5][6][7] - The voting results for the Employee Stock Ownership Plan and Stock Incentive Plan were unanimous in favor, with all three votes supporting the proposals [6][7] - The company plans to apply for a total credit line of up to 1 billion RMB from multiple commercial banks to ensure sufficient cash flow, which is also expected to benefit the company's sustainable development [7][8]

证券代码：600713 证券简称：南京医药 编号：ls2025-078 债券代码：110098 债券简称：南药转债 南京医药股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 限制性股票登记日：2025 年 5 月 30 日 ? 授予登记人数：172 人 南京医药股份有限公司（以下简称"公司"）于 2025 年 5 月 30 日完成了 2025 年限制性股票激励计划首次授予登记工作，根据《上市公司股权激励管理办法》 等相关规则的规定，现将具体情况公告如下： 一、限制性股票授予情况 （一）基本情况 议审议通过了《关于向公司 2025 年限制性股票激励计划激励对象首次授予限制 性股票的议案》，相关议案已经公司董事会薪酬与绩效考核委员会 2025 年第三 次会议审议通过。公司监事会对本次激励计划首次授予激励对象名单进行了审核 并发表了核查意见。 公司本次激励计划限制性股票实际授予情况如下： 放弃认购公司向其授予的全部限制性股票共 4 万股，调整后实际授予数量由 （二）激励对象名单及实际授予情况 本激励计 ...

Group 1 - The board of directors of Lanjian Intelligent Technology Co., Ltd. received a proposal from the controlling shareholder and chairman, Wu Yaohua, to repurchase shares to enhance investor confidence and improve shareholder returns [2][3][17] - The proposed share repurchase will utilize the company's own funds and will be conducted through the Shanghai Stock Exchange trading system [3][17] - The total amount for the share repurchase is set to be no less than RMB 10 million and no more than RMB 20 million, with a repurchase price not exceeding 150% of the average trading price over the previous 30 trading days [3][17] Group 2 - Lanjian Intelligent aims to enhance operational quality by focusing on its core business and expanding into new industries such as new energy, automotive, and aerospace [5][7] - The company plans to increase its research and development investment, which reached RMB 128 million in 2024, a year-on-year increase of 47.31% [12][13] - The company has established a strong brand presence in various industries and aims to further enhance its brand influence through high-quality solutions and after-sales services [8][10] Group 3 - The company reported a new order value of RMB 1.537 billion in 2024, representing a year-on-year growth of 39.73% [7] - As of December 31, 2024, the company had a backlog of orders amounting to RMB 1.298 billion, an increase of 18.97% compared to the previous year [7] - The company is committed to maintaining a sustainable dividend policy, proposing a cash dividend of RMB 3.30 per 10 shares for 2025, totaling approximately RMB 33.73 million [15][16] Group 4 - The company emphasizes the importance of corporate governance and has established a robust governance structure involving shareholders, the board of directors, and independent directors [19][20] - Lanjian Intelligent is focused on enhancing compliance management and internal auditing to ensure effective governance and risk management [21][22] - The company is dedicated to improving information disclosure practices to enhance transparency and protect the rights of minority investors [22][24]

证券代码：688766 证券简称：普冉股份 公告编号：2025-034 普冉半导体（上海）股份有限公司 关于调整2022年、2024年限制性 股票激励计划授予价格及授予数量的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 普冉半导体（上海）股份有限公司（以下简称"公司"）于2025年5月30日召开第二届董事会第十七次会 议及第二届监事会第十七次会议，审议通过了《关于调整公司2022年、2024年限制性股票激励计划授予 价格及授予数量的议案》，同意公司根据《上市公司股权激励管理办法》（以下简称"《管理办法》"） 等法律法规、规范性文件及《普冉半导体（上海）股份有限公司2022年限制性股票激励计划（草案）》 （以下简称"2022年激励计划"）、《普冉半导体（上海）股份有限公司2024年限制性股票激励计划（草 案）》（以下简称"2024年激励计划"）的有关规定，对上述激励计划授予价格及授予数量进行调整，其 中2022年激励计划首次授予价格由44.67元/股调整为14.85元/股，首次授予激励对象实际已授予但尚未 归属的限制性股 ...

证券代码：603151 证券简称：邦基科技 公告编号：2025-044 山东邦基科技股份有限公司 关于2024年股票期权激励计划首次授予部分 第一个行权期自主行权实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ? 行权起始日：2025年6月6日 ? 本次符合行权条件的激励对象人数：140人 ? 本次首次授予股票期权第一个行权期可行权数量：332.00万份 ? 行权股票来源：公司向激励对象定向发行人民币A股普通股股票 山东邦基科技股份有限公司（以下简称"公司"）于2025年5月13日召开了第 二届董事会第十次会议、第二届监事会第九次会议，审议通过了《关于2024年股票 期权激励计划首次授予部分第一个行权期行权条件成就的议案》。公司2024年股 票期权激励计划首次授予部分第一个行权期行权条件已经成就，现将相关事项公 告如下： 一、2024年股票期权激励计划批准及实施情况 （一）已履行的决策程序和信息披露情况 四次会议，审议通过了《关于公司<2024年股票期权激励计划（草案）>及其摘 要 的 议 案 ...

Core Points - The company has announced the first vesting period of its 2024 restricted stock incentive plan, with a total of 139,584 shares eligible for vesting [1][12][19] - The incentive plan includes performance-based criteria tied to revenue growth, with specific targets set for each vesting period [1][12][14] - The initial grant of restricted stock was adjusted from 483,727 shares to 677,218 shares, with the grant price revised from 46.32 CNY to 23.19 CNY per share [11][19][20] Group 1: Incentive Plan Details - The incentive plan involves granting 34.5519 million shares, representing 0.46% of the company's total share capital [1][9] - The vesting schedule is divided into four periods, each with a 25% vesting rate, contingent on meeting specific performance targets [1][12] - The performance targets for the first vesting period require a revenue growth rate of at least 45% compared to 2023 [1][12][14] Group 2: Approval and Implementation - The plan was approved during the company's board meetings held on March 29, 2024, and subsequent meetings confirmed the eligibility of the incentive recipients [6][7][12] - The company conducted a self-inspection regarding insider trading prior to the announcement and found no violations [7][19] - The board and supervisory committee have verified the qualifications of the incentive recipients and the fulfillment of vesting conditions [12][16][19] Group 3: Financial Implications - The company will account for the fair value of the restricted stock on the grant date and will not reassess it until the vesting date [17][18] - The vesting of restricted stock is not expected to have a significant impact on the company's financial status or operational results [18][19] - The adjustments made to the incentive plan comply with relevant regulations and are not expected to harm the interests of the company or its shareholders [19][20]

Core Viewpoint - The legal opinion letter from Shanghai Junlan Law Firm addresses the adjustments, cancellations, and vesting conditions related to the restricted stock incentive plans of Purun Semiconductor (Shanghai) Co., Ltd. for the years 2022 and 2024, confirming compliance with relevant regulations and the necessary approvals obtained [1][4][31]. Summary by Sections Approval and Authorization of Adjustments - The adjustments to the 2022 and 2024 incentive plans were approved through various resolutions, including the authorization for the board to handle related matters [4][6][7]. - The company has received necessary approvals from the shareholders' meeting for the adjustments and cancellations of the stock options [31]. Details of Adjustments - The adjustments to the grant prices and quantities of the restricted stocks are based on capital reserve transfers, stock dividends, and other corporate actions [10][11]. - The adjusted grant price for the 2022 incentive plan's initial grant was changed from 44.67 CNY/share to 14.85 CNY/share, and for the reserved grant from 56.75 CNY/share to 18.99 CNY/share [10][11]. - The adjusted grant quantity for the 2022 incentive plan's initial grant increased from 352,886 shares to 1,030,568 shares, and for the reserved grant from 49,745 shares to 145,275 shares [12][13]. Cancellations of Restricted Stocks - A total of 171,047 shares from the initial grant of the 2022 incentive plan were canceled due to 16 recipients leaving the company and not meeting vesting conditions [16][19]. - For the reserved grant of the 2022 plan, 22,103 shares were canceled, reducing the number of recipients from 75 to 69 [19]. - In the 2024 incentive plan, 102,421 shares were canceled due to similar reasons, reducing the number of recipients from 72 to 60 [19]. Vesting Conditions - The vesting period for the initial grant of the 2022 plan is from December 30, 2024, to December 29, 2025, while the reserved grant's period is from April 21, 2025, to April 21, 2026 [20][27]. - The vesting conditions require that the company does not face any adverse audit opinions and that the recipients meet specific performance criteria [21][30]. Information Disclosure - The company is required to disclose relevant information regarding the adjustments, cancellations, and vesting conditions in accordance with regulatory requirements [31][32].

Core Viewpoint - Shanghai Aiwei Electronics Technology Co., Ltd. is undergoing adjustments to its 2022 Restricted Stock Incentive Plan, including the cancellation of unvested shares and changes to the grant price and quantity of shares [4][9][10]. Group 1: Legal Opinions and Approvals - The law firm has confirmed that the necessary legal procedures for the cancellation, adjustment, and vesting of shares have been completed in accordance with relevant laws and regulations [4][12]. - The company has received approval from its board and supervisory board for the adjustments to the incentive plan, including the authorization to manage and adjust the plan [7][9][10]. Group 2: Adjustments to the Incentive Plan - The initial grant price of the restricted stock has been adjusted from RMB 53.07 per share to RMB 37.97 per share, and the number of shares granted has increased from 4.78 million to approximately 6.68 million shares [9][10]. - A total of 418,713 shares that were granted but not vested have been canceled due to various reasons, including employee departures and performance assessments [11][12]. Group 3: Vesting Conditions - The vesting conditions for the second vesting period of the incentive plan have been met, allowing for the vesting of shares for 437 eligible participants [19][21]. - The performance metrics for the second vesting period are based on revenue growth, with specific thresholds set for the company’s performance [18][19].